BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32609843)

  • 1. Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion.
    Eissa SS; Clay MR; Santiago T; Wu G; Wang L; Shulkin BL; Picarsic J; Nichols KE; Campbell PK
    Blood Adv; 2020 Jul; 4(13):2991-2995. PubMed ID: 32609843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel fusion TBL1XR1-PDGFRB in a patient with acute myeloid leukemia harboring the DEK-NUP214 fusion and clinical response to dasatinib.
    Campregher PV; Halley NDS; Vieira GA; Fernandes JF; Velloso EDRP; Ali S; Mughal T; Miller V; Mangueira CLP; Odone V; Hamerschlak N
    Leuk Lymphoma; 2017 Dec; 58(12):2969-2972. PubMed ID: 28509585
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute Lymphoblastic Leukemia Patient with Variant ATF7IP/PDGFRB Fusion and Favorable Response to Tyrosine Kinase Inhibitor Treatment: A Case Report.
    Zhang G; Zhang Y; Wu J; Chen Y; Ma Z
    Am J Case Rep; 2017 Nov; 18():1204-1208. PubMed ID: 29133777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The
    Tran TH; Nguyen JV; Stecula A; Akutagawa J; Moorman AV; Braun BS; Sali A; Mullighan CG; Shah NP; Dai Y; Devidas M; Roberts KG; Smith CC; Loh ML
    Haematologica; 2021 Aug; 106(8):2242-2245. PubMed ID: 33626861
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome.
    Iznardo H; Bredrup C; Bernal S; Gladkauskas T; Mascaró JM; Roé E; Baselga E
    Am J Med Genet A; 2022 Apr; 188(4):1233-1238. PubMed ID: 34894066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TKI dasatinib monotherapy for a patient with Ph-like ALL bearing ATF7IP/PDGFRB translocation.
    Kobayashi K; Miyagawa N; Mitsui K; Matsuoka M; Kojima Y; Takahashi H; Ootsubo K; Nagai J; Ueno H; Ishibashi T; Sultana S; Okada Y; Akimoto S; Okita H; Matsumoto K; Goto H; Kiyokawa N; Ohara A
    Pediatr Blood Cancer; 2015 Jun; 62(6):1058-60. PubMed ID: 25400122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An ocular variant of juvenile xanthogranuloma].
    Sobels M; Vaandrager W; Schalij-Delfos NE
    Ned Tijdschr Geneeskd; 2014; 158():A7889. PubMed ID: 25269639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).
    Morerio C; Acquila M; Rosanda C; Rapella A; Dufour C; Locatelli F; Maserati E; Pasquali F; Panarello C
    Cancer Res; 2004 Apr; 64(8):2649-51. PubMed ID: 15087372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneoscleral xanthogranuloma treated with chemotherapy: The room for nonsurgical management.
    Mustafa OM; Daoud YJ
    Eur J Ophthalmol; 2020 Mar; 30(2):NP23-NP26. PubMed ID: 30813780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.
    Kobayashi K; Mitsui K; Ichikawa H; Nakabayashi K; Matsuoka M; Kojima Y; Takahashi H; Iijima K; Ootsubo K; Oboki K; Okita H; Yasuda K; Sakamoto H; Hata K; Yoshida T; Matsumoto K; Kiyokawa N; Ohara A
    Br J Haematol; 2014 Jun; 165(6):836-41. PubMed ID: 24628626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of juvenile xanthogranuloma using bevacizumab.
    Ashkenazy N; Henry CR; Abbey AM; McKeown CA; Berrocal AM; Murray TG
    J AAPOS; 2014 Jun; 18(3):295-7. PubMed ID: 24767830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
    Iriyama N; Takahashi H; Naruse H; Miura K; Uchino Y; Nakagawa M; Iizuka K; Hamada T; Hatta Y; Nakayama T; Takei M
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00591. PubMed ID: 30697976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
    Apperley JF; Gardembas M; Melo JV; Russell-Jones R; Bain BJ; Baxter EJ; Chase A; Chessells JM; Colombat M; Dearden CE; Dimitrijevic S; Mahon FX; Marin D; Nikolova Z; Olavarria E; Silberman S; Schultheis B; Cross NC; Goldman JM
    N Engl J Med; 2002 Aug; 347(7):481-7. PubMed ID: 12181402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.
    Erben P; Gosenca D; Müller MC; Reinhard J; Score J; Del Valle F; Walz C; Mix J; Metzgeroth G; Ernst T; Haferlach C; Cross NC; Hochhaus A; Reiter A
    Haematologica; 2010 May; 95(5):738-44. PubMed ID: 20107158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.
    Xu X; Lu Q; Wang Z; Cai P; Zeng Z; Zhang L; Wang M; Ma L; Ruan C; Chen S
    Cancer Res Treat; 2021 Jul; 53(3):889-892. PubMed ID: 33421986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracerebral juvenile xanthogranuloma: an infrequent involvement of hystiocitosis in children.
    Torres Pérez P; Bollar Zabala A; Armendáriz Guezala M; Úrculo Bareño E
    Childs Nerv Syst; 2018 Aug; 34(8):1445-1446. PubMed ID: 29797066
    [No Abstract]   [Full Text] [Related]  

  • 17. Juvenile xanthogranuloma diagnosed by paracentesis.
    Schwartz LW; Rodrigues MM; Hallett JW
    Am J Ophthalmol; 1974 Feb; 77(2):243-6. PubMed ID: 4204591
    [No Abstract]   [Full Text] [Related]  

  • 18. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
    Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE
    Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early treatment of juvenile xanthogranuloma of the iris with subconjunctival steroids.
    Casteels I; Olver J; Malone M; Taylor D
    Br J Ophthalmol; 1993 Jan; 77(1):57-60. PubMed ID: 8435403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.